-
Polish Customer Purchased 350g Of Orforglipron And 30g Of Semaglutide.Jan 30, 2026Orforglipron (LY-3502970) is a non-peptide small-molecule GLP-1 receptor agonist with the molecular formula C₄₈H₄₈F₂N₁₀O₅ and a molecular weight of...
-
GLP-1 Agonist: Dual Effect Combination, Restructuring Metabolic TherapyFeb 07, 2026Recently, Suzhou Ruibo Biotechnology Co., Ltd. (stock code: 06938. HK), a leading enterprise in small nucleic acid drugs, officially listed on the ...
-
Happy Chinese New Year Of The Horse 2026!!!Jan 29, 2026Dear Friends, Happy Chinese New Year of the Horse 2026!!! We will be closed for 10 days from 14th February to 23th February. Regular business resum...
-
Australian Customers Repurchased Peptides Before The Chinese New Year.Jan 25, 2026In the cold winter of January 2026, our long-standing Australian client placed another significant repeat order with us. This order, totaling $2,38...
-
The American Customer Placed Their Second Order For RetatrutideJan 23, 2026Retatrutide is a novel triple receptor agonist that targets GIP, GLP-1, and glucagon receptors simultaneously. It regulates blood sugar, slows down...
-
New Requirements From Our Dutch ClientJan 15, 2026Driven by the tide of globalisation, commercial cooperation has long transcended geographical boundaries. Enterprises from different nations collab...
-
An Old Customer From Brazil Placed An Order For The Slu-pp-332 CapsuleJan 15, 2026SLU-PP-332 capsule is an innovative drug with a core component of a general estrogen receptor-related receptor (ERR) agonist. It activates the thre...
-
NA-931 Capsules And Peptide Products Are Sold To The United StatesJan 30, 2026NA-931 capsules10mg contain 10mg per capsule. U.S. customer Kenny has ordered 500 capsules. NA-931 is a peptide substance with unique biological ac...
-
Peptide New Drug Semaglutide: GLP-1 Pattern ChangesJan 31, 2026One injection per week! Novo Nordisk's new compound preparation Kyinsu has been approved by the European Union On November 26, 2025, Novo Nordi...
-
Fushimegliptin: Peptide Innovation, GLP-1 MutationJan 23, 2026Novo Nordisk Amycretin diabetes Phase II Clinical Data Release On November 25, 2025, Novo Nordisk announced that the GLP-1/Amylin double target ago...
-
GLP-1+oligonucleotides: A New Global Track For Weight Loss And Blood Sugar ReductionJan 17, 2026GLP-1 Injections 1.General Specification(in stock) (1)API(Pure powder) (2)Tablet (3)Capsule (4)Injection (5)Liquid Drops 2.Customization: We will n...
-
The Application Of Semaglutide in Controlling Blood SugarJan 21, 2026Lyophilized Semaglutide CAS 910463-68-2 Product Code: BM-2-4-043 English Name: Semaglutide CAS No.: 910463-68-2 Molecular formula: C187H291N45O59 M...













